Abstract 1880P
Background
Physicians must help patients to maintain motivation and resolve barriers to adherence to treatment, but this does not happen in many cases. The impact of cancer in the coming years will have devastating consequences for the health system since it is the third cause of mortality in the country. Therefore, a substantial change in medical education, health policies is imperative. They are future specialists, the attitudinal barriers could limit their skills and abilities in the task for general surgeons, gynecologists, otolaryngologists, and anesthetists. To detect and change barriers, implement a strategy of 180 minutes in a reflexive focus group.
Methods
Descriptive, non-blind study approved by the Research Ethics Committee (ON23-00003), informed consent was requested from 51 medical residents of the surgical areas of a general hospital who attended a psychoeducational focus group in 2 frequencies, they answered the survey about their beliefs and attitudes regarding the care of cancer patients. 3 key questions were analyzed to ensure knowledge together with reflection, reinforcing empathic attitudes and team collaboration of the participants.
Results
The subjects correctly considered the definition of oncology pre and post-intervention (84 vs 91%), that the treating physician had to give the diagnosis (55 vs 92%) that there is no correct answer for how long a patient would live (89 vs 96%), The term used by the patient to name the cancer doesn´t matter as long as they understand the disease (32 vs 42%), That they should not join the conspiracy of silence proposed by the patient or family (77 vs 91%) If they believed that there is treatment in any stage of cancer (55 vs 87%), if they should care for patients with cancer with a CPR indication vs other chronic patients with hypertensive crisis and DM (64 vs 81%), if they considered palliative care and psycho-oncology for diagnostic phases (63 vs 85%). In the qualitative aspect they left satisfied and mostly looking forward to new sessions that would allow them to carry out their work and education.
Conclusions
There was a percentage impact in generating substantive changes in the opinion of the subjects; this first step should be followed up with more studies and is of relevance to medical educators.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Universidad Autónoma de Nuevo León.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1877P - Meaning-making in the re-entry phase: A qualitative focus group study with patients with breast cancer and melanoma
Presenter: Anna Visser
Session: Poster session 05
1878P - Prevalence of burnout in GU oncologists in central Asia: BUCARE survey
Presenter: Oxana Shatkovskaya
Session: Poster session 05
1879P - Investigating the effect of family support on the mental health of patients with breast cancer
Presenter: Maryam Garousi
Session: Poster session 05
1991P - Safety and effectiveness of surgery or radiotherapy after PD-L1 Inhibitor (TQB-2450) and chemotherapy induction therapy in patients with limited-stage small cell lung cancer: A phase II trial
Presenter: Fenghuan Sun
Session: Poster session 05
1992P - A phase II safety and efficacy study of PM8002 (anti-PD-L1 x VEGF-A bispecific) combined with paclitaxel as a second-line therapy for small cell lung cancer (SCLC)
Presenter: Ying Cheng
Session: Poster session 05
1993P - Phase IIIb study of durvalumab plus platinum–etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Safety results
Presenter: Maria Dolores Isla Casado
Session: Poster session 05
1994P - Carboplatin, etoposide, bevacizumab, and atezolizumab in patients with extensive-stage SCLC – GOIRC-01-2019 CeLEBrATE ML41241 trial
Presenter: Karim Rihawi
Session: Poster session 05
1995P - Long-term benefit of atezolizumab plus chemotherapy in extensive stage small cell lung cancer (ES-SCLC): Exploratory analysis from the IMfirst study
Presenter: Maria Rosario Garcia Campelo
Session: Poster session 05
1996P - The impact of an etoposide shortage on patients with extensive-stage small cell lung cancer (ES-SCLC): Results of a natural experiment
Presenter: Claire Browne
Session: Poster session 05
1997P - A study of sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-disease small cell lung cancer
Presenter: Zhe-Hai Wang
Session: Poster session 05